Simpler Grants.gov #PAR-23-077

NIH Multidisciplinary Team Research Grant (RM1) Solicitation

The National Institutes of Health (NIH), through the National Institute of General Medical Sciences (NIGMS), is inviting applications for the Collaborative Program Grant for Multidisciplinary Teams (RM1 - Clinical Trial Optional): - Government Buyer: - National Institutes of Health (NIH) - National Institute of General Medical Sciences (NIGMS) - Purpose: - Supports highly integrated research teams (3-6 principal investigators) to address ambitious, multidisciplinary scientific questions aligned with NIGMS's mission - Projects must require significant synergy and managed team interactions - Scope and Requirements: - Research must go beyond what individual investigators can achieve alone - NIH-defined clinical trials are allowed, except those focused on safety/efficacy for clinical treatment or regulatory approval - Projects centered on community resources, technology creation, or infrastructure development are not eligible - OEMs and Vendors: - No specific OEMs or vendors are mentioned, as this is a research grant opportunity - Products/Services Requested: - No specific products or services are being procured; the opportunity funds research activities only - Notable Requirements: - Teams must be multidisciplinary and demonstrate a high level of integration and collaboration - Applications must align with the scientific priorities of NIGMS

Description

This funding opportunity announcement (FOA) supports highly integrated research teams of three to six PD/PIs to address ambitious and challenging research questions important to the mission of NIGMS. The teams are expected to achieve goals requiring considerable synergy and managed interactions, focusing on far-reaching objectives that produce major advances in their fields. Applications focused mainly on community resources, new technologies, or infrastructure development are not appropriate. The FOA allows submission of applications including NIH defined clinical trials, excluding those designed to test safety and efficacy of interventions for future clinical treatment or regulatory approval.

View original listing